These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26514310)

  • 21. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatological aspects of synthetic cannabinoid addiction.
    Inci R; Kelekci KH; Oguz N; Karaca S; Karadas B; Bayrakci A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):125-131. PubMed ID: 27028361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complexities of the cardiovascular actions of cannabinoids.
    Randall MD; Kendall DA; O'Sullivan S
    Br J Pharmacol; 2004 May; 142(1):20-6. PubMed ID: 15131000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Spice of Life...and Death: A Case Presentation and Review of Synthetic Marijuana Use in Mississippi.
    Wilkinson J; Tullos JM; Rifkin B
    J Miss State Med Assoc; 2016 Sep; 57(9):289-291. PubMed ID: 30281223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid.
    Gugelmann H; Gerona R; Li C; Tsutaoka B; Olson KR; Lung D
    Clin Toxicol (Phila); 2014 Jul; 52(6):635-8. PubMed ID: 24905571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high.
    Sherpa D; Paudel BM; Subedi BH; Chow RD
    J Community Hosp Intern Med Perspect; 2015; 5(4):27540. PubMed ID: 26333853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoid system dysfunction in mood and related disorders.
    Ashton CH; Moore PB
    Acta Psychiatr Scand; 2011 Oct; 124(4):250-61. PubMed ID: 21916860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reports of adverse health effects related to synthetic cannabinoid use in New York State.
    Papadopoulos EA; Cummings KR; Marraffa JM; Aldous KM; Li L; Ahmad N
    Am J Addict; 2017 Dec; 26(8):772-775. PubMed ID: 29105968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical increase in synthetic cannabinoid emergency-related presentations after a citywide ban: Lessons from Houston, Texas.
    Mathai D; Gordon M; Muchmore P; Matorin A; Shah A; Moukaddam N
    Bull Menninger Clin; 2016; 80(4):357-370. PubMed ID: 27936903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid.
    Takematsu M; Hoffman RS; Nelson LS; Schechter JM; Moran JH; Wiener SW
    Clin Toxicol (Phila); 2014 Nov; 52(9):973-5. PubMed ID: 25241766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid hyperemesis: a case series.
    Donnino MW; Cocchi MN; Miller J; Fisher J
    J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure.
    Argamany JR; Reveles KR; Duhon B
    Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.